BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/22/2021 8:36:46 AM | Browse: 947 | Download: 2630
 |
Received |
|
2020-12-24 14:01 |
 |
Peer-Review Started |
|
2020-12-25 00:23 |
 |
First Decision by Editorial Office Director |
|
2021-01-11 03:39 |
 |
Return for Revision |
|
2021-01-11 03:39 |
 |
Revised |
|
2021-01-19 19:24 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2021-02-03 09:53 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2021-02-12 05:13 |
 |
Articles in Press |
|
2021-02-12 05:13 |
 |
Edit the Manuscript by Language Editor |
|
2021-02-23 22:44 |
 |
Typeset the Manuscript |
|
2021-03-19 01:27 |
 |
Publish the Manuscript Online |
|
2021-03-22 08:36 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Prospective Study |
| Article Title |
Elevated interleukin-6 levels are associated with impaired outcome in cardiac ATTR amyloidosis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Selina J Hein, Maximilian Knoll, Fabian Aus dem Siepen, Jennifer Furkel, Stefan Schoenland, Ute Hegenbart, Hugo A Katus, Arnt V Kristen and Mathias Konstandin |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Alnylam Pharmaceuticals® |
PO 4510001138 |
| German Research Foundation and German Center for Cardiovascular Research Funding |
KO-3900 |
|
| Corresponding Author |
Selina J Hein, MD, Consultant Physician-Scientist, Postdoc, Department of Cardiology, Pneumology and Angiology, University Hospital Heidelberg, INF 410, Heidelberg 69120, BW, Germany. selina.hein@med.uni-heidelberg.de |
| Key Words |
Transthyretin amyloidosis; Inflammation; Heart failure; Interleukin-6; Outcome; Risk stratification |
| Core Tip |
This was a monocentric prospective trial with 106 patients suffering from transthyretin cardiomyopathy (ATTR-CM) seeking to evaluate the prognostic value of interleukin (IL)-6 in ATTR-CM. IL-6 is associated with outcome in ATTR-CM but did not further ameliorate existing risk prediction models. |
| Publish Date |
2021-03-22 08:36 |
| Citation |
Hein SJ, Knoll M, Siepen FAD, Furkel J, Schoenland S, Hegenbart U, Katus HA, Kristen AV, Konstandin M. Elevated interleukin-6 levels are associated with impaired outcome in cardiac ATTR amyloidosis. World J Cardiol 2021; 13(3): 55-67 |
| URL |
https://www.wjgnet.com/1949-8462/full/v13/i3/55.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v13.i3.55 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.